MedPath

Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction

Not Applicable
Completed
Conditions
Wrinkle
Aging Problems
Interventions
Other: Manual acupuncture
Other: Thread embedding acupuncture
Registration Number
NCT05098912
Lead Sponsor
Indonesia University
Brief Summary

This study was aimed to compare the effectiveness of polydioxanone thread embedding acupuncture and manual acupuncture on the reduction of the nasolabial fold. One cycle of therapy in the manual acupuncture group (MA) was carried out with 6 sessions of manual acupuncture therapy while one cycle of therapy in the thread embedding acupuncture group (TEA) received 1 single session of thread embedding acupuncture. The outcome of the study was assessed based on the length of the nasolabial fold as measured by a digital vernier caliper, changes in wrinkle severity rating scale, and patient's subjective opinion of her nasolabial fold using visual analog scale. Outcome measurements were carried out after completing 1 cycle, and follow up at 2 weeks, 1 month, 2 months and 3 months after completing 1 cycle.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Woman
  • Age 30-50 years old
  • WSRS scale 3 to 4
  • Willing to follow the research to completion
  • Subjects who do not have a history of filler injection and/implants, laser therapy, microdermabrasion, peeling, botulinum toxin therapy, manual acupuncture on the face, thread embedding acupuncture on the face and does not either oral or topically use collagen within 6 months
  • Body mass index of ≥ 18.5
  • Signed the informed consent
Exclusion Criteria
  • Subjects with facial muscle paralysis disorders
  • Subjects with history of keloids and/or hypertrophic scars, subjects with tumors or infection or inflammation at the treatment area
  • Subjects with allergies to stainless steel, PDO threads, topical anesthetics lidocaine
  • Pregnant and lactating subjects
  • Subjects with cancer
  • Subjects with history of bleeding disorders or are taking anticoagulant or antiplatelet.
  • Subjects suffering from fever (≥ 37.5°C), cough, fatigue
  • Subjects with blood glucose POCT (Point of Care Testing) levels of ≥ 200 mg/dl

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Manual acupunctureManual acupunctureThe subjects/population of this study is woman at age 30-50 who meet the inclusion criteria. Subjects group with manual acupuncture treatment will be treated with 6 session of manual acupuncture at: From the superior of zygomatic arch through ST 2 to LI 20 bilaterally using a needle size of 0.25 x 60 mm From the inferior of zygomatic arch through SI 18 to ST 4 bilaterally using a needle size of 0.25 x 60 mm From ST 7 to ST 4 bilaterally using a needle size of 0.25 x 60 mm Along the nasolabial crease through ST 4 to the bilateral EXHN-8 using a needle size of 0.25 x 40 mm
Thread embedding acupunctureThread embedding acupunctureThe subjects/population of this study is woman at age 30-50 who meet the inclusion criteria. Subjects group with thread embedding acupuncture group treatment will be treated with 1 session of thread embedding acupuncture at: From the superior of zygomatic arch through ST 2 to LI 20 bilaterally using a gauge and length of the needle of 31G x 50 mm From the inferior of zygomatic arch through SI 18 to ST 4 bilaterally using a gauge and length of the needle of 31G x 50 mm From ST 7 to ST 4 bilaterally using a gauge and length of the needle of 31G x 50 mm Along the nasolabial crease through ST 4 to the bilateral EXHN-8 using a gauge and length of the needle of 31G x 30 mm
Primary Outcome Measures
NameTimeMethod
Nasolabial fold lengthBefore intervention (baseline), after completing 1 cycle, at 2 weeks, 1 month, 2 month, and 3 month follow up

Mean difference of nasolabial fold length (measured using digital vernier calipers in millimeters) between two groups

Wrinkle severity rating scale (WSRS)Before intervention (baseline), after completing 1 cycle, at 2 weeks, 1 month, 2 month, and 3 month follow up

Mean difference of WSRS between two groups

Secondary Outcome Measures
NameTimeMethod
Visual analog scale (VAS)Before intervention (baseline), after completing 1 cycle, at 2 weeks, 1 month, 2 months, and 3 months follow up

Mean difference of VAS (patient's subjective opinion of her nasolabial fold) between two groups

Trial Locations

Locations (1)

Cipto Mangunkusumo Hospital

🇮🇩

Jakarta Pusat, DKI Jakarta, Indonesia

© Copyright 2025. All Rights Reserved by MedPath